Lineage Cell Therapeutics Inc (LTS:0HNF)
$ 1.07 0 (0%) Market Cap: 137.84 Mil Enterprise Value: 100.87 Mil PE Ratio: 0 PB Ratio: 2.55 GF Score: 60/100

Q2 2020 Lineage Cell Therapeutics Inc Earnings Call Transcript

Aug 06, 2020 / 09:30PM GMT
Operator

Welcome to the Lineage Cell Therapeutics Second Quarter 2020 Conference Call. (Operator Instructions) An audio webcast is available on the Investors section of Lineage's website at www.lineagecell.com. This call is subject to copyright as the property of Lineage and recordings, reproduction or transmission of this call without the expressed written consent of Lineage are strictly prohibited. As a reminder, today's call is being recorded.

I would now like to introduce your host for today's conference, Ioana Hone, Director of Investor Relations at Lineage. Ms.Hone, please go ahead.

Ioana C. Hone
Lineage Cell Therapeutics, Inc. - Director of IR

Thank you, Chino. Good afternoon, and thank you for joining us. A press release reporting our second quarter 2020 financial results was issued earlier today August 6, 2020, and can be found on the Investors section of our website. Please note that today's conference call and webcast will contain forward-looking statements within the meaning of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot